Cbre Investment Management Listed Real Assets LLC reduced its position in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 65.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 55,531 shares of the company's stock after selling 106,631 shares during the quarter. Cbre Investment Management Listed Real Assets LLC's holdings in Exelon were worth $2,090,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Exelon by 109.0% in the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company's stock worth $238,608,000 after acquiring an additional 3,068,309 shares during the period. State Street Corp grew its position in Exelon by 3.7% during the third quarter. State Street Corp now owns 60,169,219 shares of the company's stock valued at $2,439,862,000 after buying an additional 2,156,259 shares during the period. Nordea Investment Management AB grew its position in Exelon by 418.1% during the fourth quarter. Nordea Investment Management AB now owns 2,501,392 shares of the company's stock valued at $94,152,000 after buying an additional 2,018,604 shares during the period. FMR LLC grew its position in Exelon by 18.7% during the third quarter. FMR LLC now owns 11,782,549 shares of the company's stock valued at $477,782,000 after buying an additional 1,858,502 shares during the period. Finally, Assenagon Asset Management S.A. grew its position in Exelon by 212.2% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,903,482 shares of the company's stock valued at $71,647,000 after buying an additional 1,293,753 shares during the period. 80.92% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the stock. Guggenheim upgraded shares of Exelon from a "neutral" rating to a "buy" rating in a research report on Thursday, January 23rd. Morgan Stanley reduced their price target on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating on the stock in a research report on Friday, November 22nd. BMO Capital Markets reiterated an "outperform" rating on shares of Exelon in a research report on Tuesday, February 4th. Evercore ISI upgraded shares of Exelon from an "in-line" rating to an "outperform" rating and boosted their price objective for the company from $43.00 to $44.00 in a research report on Tuesday, January 21st. Finally, Barclays upped their price target on shares of Exelon from $42.00 to $48.00 and gave the stock an "overweight" rating in a report on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $44.13.
Read Our Latest Stock Analysis on Exelon
Insider Buying and Selling at Exelon
In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the completion of the sale, the executive vice president now directly owns 2,271 shares of the company's stock, valued at approximately $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.10% of the company's stock.
Exelon Stock Up 0.5 %
NASDAQ:EXC traded up $0.23 during mid-day trading on Friday, reaching $43.11. The company's stock had a trading volume of 6,670,169 shares, compared to its average volume of 7,408,646. Exelon Co. has a 1 year low of $34.01 and a 1 year high of $45.19. The stock has a fifty day moving average of $40.74 and a 200-day moving average of $39.54. The firm has a market capitalization of $43.33 billion, a PE ratio of 17.60, a price-to-earnings-growth ratio of 2.86 and a beta of 0.51. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61.
Exelon (NASDAQ:EXC - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 earnings per share for the quarter, topping analysts' consensus estimates of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period last year, the firm earned $0.60 earnings per share. Equities research analysts forecast that Exelon Co. will post 2.64 earnings per share for the current year.
Exelon Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.71%. This is a positive change from Exelon's previous quarterly dividend of $0.38. The ex-dividend date of this dividend is Monday, February 24th. Exelon's dividend payout ratio is presently 65.31%.
Exelon Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Featured Stories

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.